Would riluzole be efficacious in the new ALS trial design?

E. Verstraete; J.H. Veldink; L.H. van den Berg

Would riluzole be efficacious in the new ALS trial design?

Translated title of the contribution: Would riluzole be efficacious in the new ALS trial design?

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Would riluzole be efficacious in the new ALS trial design?
Original language	Undefined/Unknown
Pages (from-to)	949-950
Number of pages	2
Journal	Lancet Neurology
Volume	9
Issue number	10
Publication status	Published - 2010

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Cite this

@article{54900d4822164072b2d439747ac240bc,

title = "Would riluzole be efficacious in the new ALS trial design?",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "E. Verstraete and J.H. Veldink and \{van den Berg\}, L.H.",

year = "2010",

language = "Undefined/Unknown",

volume = "9",

pages = "949--950",

journal = "Lancet Neurology",

issn = "1474-4422",